|
Centaur accepts change as a constant, and continuously innovates to remain significant. Centaur has built knowledge sharing relationships with the pharmaceutical majors in areas of product development, custom synthesis, contract research and contract manufacturing. Centaur formulations and API are exported across 5 continents and more than 60 countries including regulated markets.
Formulations
Centaur ranks among India's TOP 50 pharmaceutical companies by prescriptions (CMarc) and by stockist audit (ORG-IMS). Centaur's All-India network includes a 1000 strong sales force that covers 250,000 doctors and 250,000 retailers every month. Over 50 million prescriptions of Centaur brands are generated by doctors of all specialities, annually.
Prescription audits (ORG-IMS & CMarc) confirm that Sinarest is a clear leader in the Indian Anti-Cold market. One prescription of Sinarest is generated every second by a doctor in India!
Centaur has demonstrated its competence in transforming products into strong brands, reinforced by successful extensions, resulting in a formidable presence in key therapy areas. Centaur brands are leaders in six therapeutic segments and rank among the top 3 in six other therapeutic segments.
Centaur's manufacturing facilities at GOA conform to WHO-GMP standards, and dosage forms include tablets liquids, injectables (vials and ampoules), eye and ear drops, and ointments.
CRAM
The current pharma scenario has driven a shift, away from in-house R&D and production to contract research and manufacturing (CRAM). A fully scalable 25,000 square metres formulations facility conforming to USFDA / EU standards has been set up in Pune with a focus on oral solids.
API
Centaur is India's largest manufacturer and exporter of Psychotropic API and have introduced 24 API for the first time in India. Our API manufacturing facility near Mumbai conforms to USFDA standards and our clientele includes Big Pharma, generic majors and Indian multinationals. Our specialisation ranges from API and intermediates to custom synthesis and process chemistry. An integrated approach ensures that we can scale up capabilities from conceptualisation to commercialisation.
CRO
A 10,000 square feet, ultra-modern, contract research organisation (CRO) with a 36 bed clinical pharmacology unit (CPU), has been set up at Centaur House, our corporate headquarters. Facilities include Bio-availability (BA), Bio-equivalence (BE), Bio-analysis & Clinical trials. State-of-the-art R&D laboratories dedicated to formulations and API, approved by the Government of India are also located at Centaur House.
Future
By strategically positioning itself for collaborative relationships, Centaur has tied up with the world's leading players, by offering high performance value options and critical capabilities.
We believe that our core competencies in API, formulations, CRAM and CRO will enhance business volumes and help us ascend the pharmaceutical value chain. This would help us realise our vision of emerging as a 'fully integrated global pharmaceutical player'. |
